At Eagle Pharmaceuticals, we are committed to making meaningful improvements in patients’ lives – and that commitment extends beyond our development of innovative medicines. Through our Patient Financial Assistance Program for BELRAPZO® (bendamustine HCI injection), and donations of RYANODEX® (dantrolene sodium) for injectable suspension to non-profit missions, we allocate a portion of our time and resources to helping patients in need.

Clefts of the lip and palate affect more than 1 in 1,000 newborn babies around the world. Our partnerships with global organizations like Medical Missions for Children, Global Smile Foundation, and the World Pediatric Project, allow us to provide access to dantrolene sodium during surgeries for these children, as well as patients with microtia, and other defects.

Eagle Pharmaceuticals is proud to provide RYANODEX® for these healthcare providers in the event of a malignant hyperthermia crisis. In 2018 alone, RYANODEX® vials were available for over 250 surgeries in Guatemala, Peru, Belize, El Salvador, and Tanzania.

Our dedicated work begins in the lab,
but it’s our social responsibility to
expand our reach, and make a
difference in the lives of patients.